Which of the following statements are true?
People with prediabetes:
A. have an increased incidence of peripheral neuropathy.
B. have a decreased incidence of peripheral neuropathy.
C. have the same incidence of peripheral neuropathy as the general population.
According to the American Diabetes Association, before people develop type 2 diabetes, they almost always have "prediabetes" — blood glucose levels that are higher than normal but not yet high enough to be diagnosed as diabetes. Also known as impaired glucose tolerance, prediabetes is an epidemic by any definition. In 2015, according to the CDC, 34% of all US adults, 84 million people, were prediabetic and 90% were unaware that they had it.
A recent study found that individuals with prediabetes are basically at equal risk to develop peripheral neuropathy as are newly diagnosed diabetics–in the range of 50%. In another study, researchers reviewed the scientific literature extensively and looked at the possibility of prediabetics being more prone to peripheral neuropathy than the general population. The researchers found the scientific literature indicated 18% of prediabetics have peripheral neuropathy.
Surprisingly, the correlation between prediabetes and peripheral neuropathy is not generally well known by physicians. A study in the journal Neurologist found that approximately 40% of all patients who were diagnosed with idiopathic neuropathy, i.e. a neuropathy in which doctors found no identifiable cause, actually had prediabetes. So, the science would indicate that prediabetes is certainly a risk factor for developing peripheral neuropathy.
The correct answer is:
A. People with prediabetes have an increased incidence of peripheral neuropathy.
NeuRemedy® improves the function of the nerves in the feet and legs.* NeuRemedy® is licensed by Health Canada to support the healthy function of nerves in individuals with polyneuropathy.*